Ngā hua rapu kaituhi

1

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association? mā Nadiya Hussain, Muntaha Naeem, David J. Pinato

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) mā David J. Pinato, Bernard V. North, Rohini Sharma

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma mā Chandan Sanghera, Jhia Jiat Teh, David J. Pinato

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy mā Matthias Pinter, David J. Pinato, Pierluigi Ramadori, Mathias Heikenwälder

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Hepatocellular carcinoma mā David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma mā Philip J. Johnson, David J. Pinato, Anton Kalyuzhnyy, Hidenori Toyoda

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

PD-L1 mā Anthousa Kythreotou, Abdul Siddique, Francesco Mauri, Mark Bower, David J. Pinato

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma mā Michael Flynn, Anwar A. Sayed, Rohini Sharma, Abdul Siddique, David J. Pinato

I whakaputaina 2018

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma mā David J. Pinato, Francesco Mauri, Rathi Ramakrishnan, Lutful Wahab, Tyler Lloyd, Rohini Sharma

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy mā Leila Motedayеn Aval, James E. Pease, Rohini Sharma, David J. Pinato

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma mā Coşkun Özer Demirtas, Antonio D’Alessio, Lorenza Rimassa, Rohini Sharma, David J. Pinato

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? mā Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David J. Pinato, Lorenza Rimassa

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer mā David J. Pinato, Robert J. Shiner, Michael J. Seckl, Justin Stebbing, Rohini Sharma, Francesco Mauri

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients mā Alessia Dalla Pria, David J. Pinato, Jennifer Roe, Kikkeri N. Naresh, Mark Nelson, Mark Bower

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future mā Amit G. Singal, Mark Yarchoan, Adam C. Yopp, Gonzalo Sapisochín, David J. Pinato, Anjana Pillai

I whakaputaina 2024

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior mā David J. Pinato, James R. Black, Sebastian Trousil, Roberto Dina, Pritesh Trivedi, Francesco Mauri, Rohini Sharma

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis mā Dariusz Lachowski, Ernesto Cortés, Alistair Rice, David J. Pinato, Krista Rombouts, Armando E. del Río Hernández

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review mā Peter R. Galle, Richard S. Finn, Catherine Mitchell, Kerigo Ndirangu, Zahra Ramji, Gabrielle Redhead, David J. Pinato

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Immunotherapy in Hepatocellular Carcinoma mā Claudia Angela Maria Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI) mā David J. Pinato, Justin Stebbing, Mitsuru Ishizuka, Shahid A. Khan, Harpreet Wasan, Bernard V. North, Keiichi Kubota, Rohini Sharma

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - David J. Pinato

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association? mā Nadiya Hussain, Muntaha Naeem, David J. Pinato

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) mā David J. Pinato, Bernard V. North, Rohini Sharma

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma mā Chandan Sanghera, Jhia Jiat Teh, David J. Pinato

NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy mā Matthias Pinter, David J. Pinato, Pierluigi Ramadori, Mathias Heikenwälder

Hepatocellular carcinoma mā David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma mā Philip J. Johnson, David J. Pinato, Anton Kalyuzhnyy, Hidenori Toyoda

PD-L1 mā Anthousa Kythreotou, Abdul Siddique, Francesco Mauri, Mark Bower, David J. Pinato

Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma mā Michael Flynn, Anwar A. Sayed, Rohini Sharma, Abdul Siddique, David J. Pinato

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma mā David J. Pinato, Francesco Mauri, Rathi Ramakrishnan, Lutful Wahab, Tyler Lloyd, Rohini Sharma

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy mā Leila Motedayеn Aval, James E. Pease, Rohini Sharma, David J. Pinato

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma mā Coşkun Özer Demirtas, Antonio D’Alessio, Lorenza Rimassa, Rohini Sharma, David J. Pinato

Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? mā Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David J. Pinato, Lorenza Rimassa

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer mā David J. Pinato, Robert J. Shiner, Michael J. Seckl, Justin Stebbing, Rohini Sharma, Francesco Mauri

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients mā Alessia Dalla Pria, David J. Pinato, Jennifer Roe, Kikkeri N. Naresh, Mark Nelson, Mark Bower

Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future mā Amit G. Singal, Mark Yarchoan, Adam C. Yopp, Gonzalo Sapisochín, David J. Pinato, Anjana Pillai

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior mā David J. Pinato, James R. Black, Sebastian Trousil, Roberto Dina, Pritesh Trivedi, Francesco Mauri, Rohini Sharma

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis mā Dariusz Lachowski, Ernesto Cortés, Alistair Rice, David J. Pinato, Krista Rombouts, Armando E. del Río Hernández

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review mā Peter R. Galle, Richard S. Finn, Catherine Mitchell, Kerigo Ndirangu, Zahra Ramji, Gabrielle Redhead, David J. Pinato

Immunotherapy in Hepatocellular Carcinoma mā Claudia Angela Maria Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato

A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI) mā David J. Pinato, Justin Stebbing, Mitsuru Ishizuka, Shahid A. Khan, Harpreet Wasan, Bernard V. North, Keiichi Kubota, Rohini Sharma

Ngā utauta rapu:

Ngā marau whai pānga